
National
FDA Vaccine Advisory Panel Meets to Discuss Future COVID-19 Vaccine Formula
The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) held a full-day public meeting on May 28, 2026, to discuss and make recommendations regarding the 2026-2027 COVID-19\u2026